Literature DB >> 16432895

Enhancing recombinant glycoprotein sialylation through CMP-sialic acid transporter over expression in Chinese hamster ovary cells.

Niki S C Wong1, Miranda G S Yap, Daniel I C Wang.   

Abstract

Glycosylation engineering strategies that are currently used to improve quality of recombinant glycoproteins involve the manipulation of glycosyltransferase and/or glycosidase expression. We explored the possibility that over expressing nucleotide sugar transporters, particularly the CMP-sialic acid transporter (CMP-SAT) would improve the sialylation process in Chinese hamster ovary cells (CHO). Our hypothesis was that increasing CMP-SAT in the cells through recombinant means would increase the transport of CMP-sialic acid into the Golgi, resulting in an increased CMP-sialic acid intra-lumenal pool and increased sialylation of the proteins produced. We report the construction of the CMP-SAT expression vector (pcDNA-SAT) using hamster CMP-SAT (GenBank accession number Y12074) and demonstrated its functionality using Lec2 CHO mutant cells. Transfection of pcDNA-SAT into CHO IFN-gamma, a CHO cell line producing recombinant human interferon-gamma (IFN-gamma) resulted in single clones that had 2-20 fold increase in total CMP-SAT expression at the transcript level and 1.8-2.8 fold increase in CMP-SAT at the protein level when compared to untransfected parent CHO IFN-gamma. This resulted in 4%-16% increase in site sialylation of IFN-gamma. There was also a higher proportion of the more sialylated IFN-gamma glycans produced by the clones. We have thus established a novel strategy for sialylation improvement in recombinant protein production that can be considered singly or along with existing glycosylation improvement strategies, including glycosyltransferase over expression and nucleotide sugar feeding. These multiprong approaches can possibly bring us closer toward the goal of maximum and consistent sialylation in glycoprotein production using mammalian cells. (c) 2006 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16432895     DOI: 10.1002/bit.20815

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  13 in total

1.  Targeted genetic modification of cell lines for recombinant protein production.

Authors:  Niall Barron; Olga Piskareva; Mohan Muniyappa
Journal:  Cytotechnology       Date:  2007-02-28       Impact factor: 2.058

2.  Chinese hamster ovary (CHO) host cell engineering to increase sialylation of recombinant therapeutic proteins by modulating sialyltransferase expression.

Authors:  Nan Lin; Joaquina Mascarenhas; Natalie R Sealover; Henry J George; Jeanne Brooks; Kevin J Kayser; Brian Gau; Isil Yasa; Parastoo Azadi; Stephanie Archer-Hartmann
Journal:  Biotechnol Prog       Date:  2015-03-01

3.  Glycoengineering of Mammalian Expression Systems on a Cellular Level.

Authors:  Kelley M Heffner; Qiong Wang; Deniz Baycin Hizal; Özge Can; Michael J Betenbaugh
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

4.  Enhancement of sialylation in rIgG in glyco-engineered Chinese hamster ovary cells.

Authors:  Thi Sam Nguyen; Ryo Misaki; Takao Ohashi; Kazuhito Fujiyama
Journal:  Cytotechnology       Date:  2020-03-03       Impact factor: 2.058

5.  Model-Driven Engineering of N-Linked Glycosylation in Chinese Hamster Ovary Cells.

Authors:  Christopher S Stach; Meghan G McCann; Conor M O'Brien; Tung S Le; Nikunj Somia; Xinning Chen; Kyoungho Lee; Hsu-Yuan Fu; Prodromos Daoutidis; Liang Zhao; Wei-Shou Hu; Michael Smanski
Journal:  ACS Synth Biol       Date:  2019-10-18       Impact factor: 5.110

Review 6.  Sialylation as an Important Regulator of Antibody Function.

Authors:  Ravi Vattepu; Sunny Lyn Sneed; Robert M Anthony
Journal:  Front Immunol       Date:  2022-04-07       Impact factor: 8.786

Review 7.  Glycoengineering Chinese hamster ovary cells: a short history.

Authors:  Roberto Donini; Stuart M Haslam; Cleo Kontoravdi
Journal:  Biochem Soc Trans       Date:  2021-04-30       Impact factor: 5.407

8.  Biological Insights into Therapeutic Protein Modifications throughout Trafficking and Their Biopharmaceutical Applications.

Authors:  Xiaotian Zhong; Jill F Wright
Journal:  Int J Cell Biol       Date:  2013-04-18

9.  Multiplexed engineering glycosyltransferase genes in CHO cells via targeted integration for producing antibodies with diverse complex-type N-glycans.

Authors:  Ngan T B Nguyen; Jianer Lin; Shi Jie Tay; Jessna Yeo; Terry Nguyen-Khuong; Yuansheng Yang
Journal:  Sci Rep       Date:  2021-06-21       Impact factor: 4.379

10.  Inhibition of poly-LacNAc biosynthesis with release of CMP-Neu5Ac feedback inhibition increases the sialylation of recombinant EPO produced in CHO cells.

Authors:  Chung-Geun Lee; Myung Jin Oh; Seung-Yeol Park; Hyun Joo An; Jung Hoe Kim
Journal:  Sci Rep       Date:  2018-05-08       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.